Research

A systematic review on the cardiovascular pharmacology of Melica officinalis Gaertn. 

This systematic review of clinical trials evaluating the effect of Amla on cardiovascular pharmacology was published in 2018. It included 19 cell culture, animal and human clinical studies with the terms “antioxidant, arrhythmia, cardioprotective, cardiotoxicity, heart disease, heart failure, hyperlipidemia, hypertension, myocardial dysfunction and oxidative stress”.  

References:

Hashem-Dabaghian, F., Ziaee, M., Ghaffari, S., Nabati, F., & Kianbakht, S. (2018). A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn. Journal of cardiovascular and thoracic research, 10(3), 118–128. https://doi.org/10.15171/jcvtr.2018.20 

Ingredient in this research

Let’s keep in touch

Don’t worry we only send updates monthly on offers, product changes, and new opportunities for you.

Due to increased order volumes, some orders may experience shipping delays. Thank you for your patience and understanding.
×
Why Choose to Subscribe and Save?
  • Automatically re-order your favorite products on your schedule.
  • Easily change the products or shipping date for your upcoming Scheduled Orders.
  • If you decide a subscription is not for you, it can be cancelled after 2 renewals.